Parts and accessories for Eppendorf EpMotion 5075 automated liquid handler upgrade

The U.S. Food and Drug Administration, through its Office of Acquisitions and Grants Services, has issued a Sources Sought Notice to identify qualified vendors capable of supplying compatible parts and accessories for the Eppendorf epMotion 5075 automated liquid handler, primarily used in next-generation sequencing library preparation workflows. This market research solicitation, identified by number 75F40126SSN134158, seeks information on the availability of specific laboratory accessories including dispensing tools, tip carriers, 96-well and 384-well racks, deep well plates, PCR plates, reservoirs, and biohazard waste bags, all of which must be new, sterile, PCR clean, DNase/RNase-free, and technically compatible with the epMotion 5075 system. Minimum specifications are detailed for each item, such as autoclavable polypropylene waste bags with 50 μm thickness and low-retention tip racks, with equivalent products permitted only if full technical equivalence is substantiated with documentation. All submissions must comply with the Buy American Act and Made in America requirements, and vendors must disclose the country of manufacture for each item. Respondents are required to submit capability statements via email to Suzanne Martella at suzanne.martella@fda.hhs.gov no later than May 18, 2026, at 2:00 PM Central Time, with the solicitation number clearly referenced. Proposals must include company information, SAM registration details, UEI number, business size status, technical documentation proving compliance with specifications, and evidence of prior performance, all contained entirely within the submission without external links or references. No formal contract clauses, evaluation factors, pricing data, or delivery terms are included in this notice, as it is strictly a pre-solicitation market research tool to assess industry capability and availability. Deliveries, if a contract results from this effort, are expected to be made within 30 days of award to the FDA/CBER facility located at 10903 New Hampshire Ave., Silver Spring, MD 20993, with acceptance governed by government inspection at the delivery point. The notice does not specify contract value, payment terms, or FOB conditions, and all contractual details will be determined in a future solicitation based on responses received.